More than half of new drugs entering the German healthcare system have not been shown to add benefit, argue researchers in The BMJ today. Beate Wieseler and colleagues at the German health technology assessment agency IQWiG (Institute for Quality and Efficiency in Health Care) say that international drug development processes and policies are responsible and… Read More »
After breathlessly ascending the peak of inflated expectations, and careening down through the trough of despair, digital health seems poised to re-emerge, battered but not beaten, in the form of digital medicine: digital health plus evidence plus humility. Andy Coravos, CEO of Elektra Labs and co-organizer of the 2019 Harvard Digital Medicine Symposium. (Photo credit:… Read More »
Robotic surgery was never approved for mastectomy or any other cancer-related treatment, but that has hardly deterred doctors in the operating suite. The equipment is widely used to operate on patients with various malignancies, from breast cancer to prostate cancer. Yet there have long been questions about how well doctors are trained on the machines,… Read More »
Timothy Caulfield felt as if blood was pooling in his brain. He was hanging upside down by his ankles, his gravity boots strapped to a bar, and his crew was worried he might kill himself. In theory, inversion therapy claims to detoxify and drain the lymphatic system, and decongest the organs. But, while many detox… Read More »
Since the 1990s China has seen a dramatic increase in the number of men seeking treatment for impotence. Everett Yuehong Zhang argues in The Impotence Epidemic that this trend represents changing public attitudes about sexuality in an increasingly globalized China. In this ethnography he shifts discussions of impotence as a purely neurovascular phenomenon to a… Read More »